search
Back to results

Impact of Lifestyle Modification on the Development of Dementia, Chronic Kidney Disease, Diabetes, Chronic Obstructive Pulmonary Disease, Cancers and Cardiovascular Disease in a Thai General Population

Primary Purpose

Dementia, Diabetes Mellitus, Chronic Kidney Disease

Status
Active
Phase
Not Applicable
Locations
Thailand
Study Type
Interventional
Intervention
4 x 4 lifestyle modification
Sponsored by
Sanpasitthiprasong Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Dementia focused on measuring Lifestyle modification, Primary prevention, Community-based intervention, Randomized control trial

Eligibility Criteria

45 Years - 75 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Thai nationality
  • Age 45-75 years
  • Have resided in the Ubon Ratchathani's villages for at least 1 year
  • Those giving written informed consent to participate in the research project

Exclusion Criteria:

  • Known case of dementia, chronic kidney disease, diabetes, chronic obstructive pulmonary disease, cancers and cardiovascular disease
  • Unable to communicate well in Thai
  • Unable to move or get physical exercise
  • Those at risk of having complications from performing physical exercise
  • Those diagnosed with cancers of any system/ organ or those in the end of life period

Sites / Locations

  • Sanpasitthiprasong Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Lifestyle modification

Control

Arm Description

4 x 4 lifestyle modification intervention, addressing four health behaviors including physical activity, diet, smoking and alcohol drinking, at four different levels, i.e. individual, household, group/ knowledge management, and community levels

No special intervention will be given. Prevention and treatment in normal practice is allowed

Outcomes

Primary Outcome Measures

Dementia
Number of participants with dementia. Incident dementia will be diagnosed by medical specialists (Neuro-Med) following a battery of screening tests, including mini-mental state exam, depression and clock drawing tests.

Secondary Outcome Measures

Type 2 diabetes mellitus
Number of participants with type 2 diabetes mellitus. Diabetes mellitus is biochemically and clinically diagnosed.
Cardiovascular disease
Number of participants with cardiovascular disease. Clinical diagnosis of cardiovascular disease. Diagnostic information will be obtained from medical records review and service reimbursement data.
Cancers
Number of participants with cancers. Diagnostic information will be obtained from medical records review and service reimbursement data.
Chronic obstructive pulmonary disease
Number of participants with physician-diagnosed chronic obstructive pulmonary disease. Diagnostic information will be obtained from medical records review and service reimbursement data.
Mortality
All-cause mortality retrieved from death certificate database, which captures deaths nationwide, dates of death and related causes.
Blood sugar
Blood sugar assessed as fasting plasma glucose and glycated hemoglobin (HbA1c)
Blood lipids
Blood lipids include total, LDL- and HDL-cholesterol and triglyceride

Full Information

First Posted
November 16, 2016
Last Updated
May 30, 2017
Sponsor
Sanpasitthiprasong Hospital
Collaborators
Dementia Association of Thailand, Diabetes Association of Thailand, The Endocrine Society of Thailand, Nephrology Society of Thailand, Thai Dietetic Society, Ubon Ratchathani Public Health Office, Thailand
search

1. Study Identification

Unique Protocol Identification Number
NCT02967406
Brief Title
Impact of Lifestyle Modification on the Development of Dementia, Chronic Kidney Disease, Diabetes, Chronic Obstructive Pulmonary Disease, Cancers and Cardiovascular Disease in a Thai General Population
Official Title
Impact of Lifestyle Modification on Prevention of Dementia, Chronic Kidney Disease, Diabetes, Chronic Obstructive Pulmonary Disease, Cancers and Cardiovascular Disease in a Thai General Population: Cluster Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
May 2017
Overall Recruitment Status
Active, not recruiting
Study Start Date
March 2016 (undefined)
Primary Completion Date
March 2027 (Anticipated)
Study Completion Date
August 2027 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Sanpasitthiprasong Hospital
Collaborators
Dementia Association of Thailand, Diabetes Association of Thailand, The Endocrine Society of Thailand, Nephrology Society of Thailand, Thai Dietetic Society, Ubon Ratchathani Public Health Office, Thailand

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This is a community-based cluster randomized control trial aimed to investigate the impact of lifestyle modification (diet, physical activity, alcohol drinking and smoking) on the development of dementia, diabetes, chronic kidney disease, cancers, chronic obstructive pulmonary disease and cardiovascular disease in an intermediate risk population in mixed urban-rural areas of Ubon Ratchathani.
Detailed Description
This is a community-based cluster randomized control trial aimed to investigate the impact of lifestyle modification (diet, physical activity, alcohol drinking and smoking) on the development of dementia, diabetes, chronic kidney disease, cancers, chronic obstructive pulmonary disease and cardiovascular disease in an intermediate risk population in mixed urban-rural areas of Ubon Ratchathani. Objectives: examine the impact of lifestyle modification on the development of dementia, diabetes, chronic kidney disease, cancers, chronic obstructive pulmonary disease and cardiovascular disease in an intermediate risk population in Ubon Ratchathani examine the economic impact of lifestyle modification on prevention of dementia, diabetes, chronic kidney disease, cancers, chronic obstructive pulmonary disease and cardiovascular disease in an intermediate risk population in Ubon Ratchathani Study design: community-based cluster randomized control trial Setting: 60 villages randomly selected from mixed urban-rural areas in 15 districts of Ubon Ratchathani province. Study population: 3,600 apparently healthy men and women aged 45-75 years who have resided in the village selected for at least one year. 4,000 men and women will be approached and screened. Screening and baseline assessment: After community consent, potential participants will be informed about the details of the project. For those who are willing to participate, written informed consent will be given before carrying out all research procedures. Participants will be questioned about their demographic characteristics, medical and family history, health behaviours including diet, physical activity, alcohol drinking and smoking. Physical activity will be assess using the Global Physical Activity Questionnaire (GPAQ) and diet will be assessed using 24 hour food recall. Their cognitive function will be assessed using the Mini-Mental State Exam (MMSE), Thai version, and clock drawing test and depression test will also be performed. Physical examination includes weight, height, blood pressure, waist and hip circumference as well as physical fitness test. Fasting blood samples will be collected for the following laboratory tests: Complete blood count, creatinine, estimated glomerular filtration rate (eGFR), fasting plasma glucose, glycated haemoglobin (HbA1c), total cholesterol, triglyceride, HDL and estimated LDL-cholesterol, serum glutamic oxaloacetic transaminase (SGOT), serum glutamic pyruvic transaminase (SGPT), thyroid stimulating hormone (TSH), Ca++, PO4-, urine creatinine/albumin, urine sodium & potassium. Interventions: Participants in 30 villages in the intervention group will be given 4x4 lifestyle modification intervention, which will address four health behaviors (diet, physical activity, alcohol drinking and smoking) at four different levels: individual, household, knowledge management and community levels. A new computer program called 'iActive' will be used. The program was adapted from the GPAQ with add-on functions to allow real-time assessment and presentation of the energy expenditure along with recommendations specific to each individual. Dietary counseling will be given individually following assessment using a new dietary assessment program called Dietary Assessment Scanning Calculator (DISC). Home visit will be done every 3 months by responsible nurses and village health volunteers in order to assess and give simple counseling about health behaviors. Knowledge management will be undertaken through meetings and forums between participants and villages with support from trained nurses. Situation analysis and agreed community action will be encouraged to address community problems concerning four health behaviors. A combination of these intensive interventions will be given for 3 years. Follow-up and outcome ascertainment: Participants will be followed at 1, 2, 5 and 10 years after baseline assessment for the development of the outcomes of interest. In each follow-up, procedures identical to baseline assessment will be done. Primary outcome: Incident dementia Incident dementia will be ascertained by a battery of screening test (MMSE, clock drawing and depression tests) and those with abnormal test results will be referred to neuro-medicine specialists at the regional hospital for further investigations and diagnosis. Secondary outcomes: Type 2 diabetes mellitus chronic kidney disease cancers chronic obstructive pulmonary disease cardiovascular disease body mass index waist circumference blood pressure Fasting plasma glucose HbA1c Lipids (total cholesterol, triglyceride, HDL and estimated LDL) Tertiary outcomes: MMSE scores or Cognitive decline Alzheimer's disease Physical activity levels Dietary intake prevalence of current smokers prevalence of alcohol consumption

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dementia, Diabetes Mellitus, Chronic Kidney Disease, Cardiovascular Diseases, Malignancy, Chronic Obstructive Pulmonary Disease
Keywords
Lifestyle modification, Primary prevention, Community-based intervention, Randomized control trial

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
3600 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Lifestyle modification
Arm Type
Experimental
Arm Description
4 x 4 lifestyle modification intervention, addressing four health behaviors including physical activity, diet, smoking and alcohol drinking, at four different levels, i.e. individual, household, group/ knowledge management, and community levels
Arm Title
Control
Arm Type
No Intervention
Arm Description
No special intervention will be given. Prevention and treatment in normal practice is allowed
Intervention Type
Behavioral
Intervention Name(s)
4 x 4 lifestyle modification
Intervention Description
Participants in the intervention group will be given 4x4 lifestyle modification intervention, which will address four health behaviors (diet, physical activity, alcohol drinking and smoking) at four different levels: individual, household, knowledge management and community levels. A new computer program called 'iActive' adapted from the GPAQ with add-on functions to allow real-time assessment and presentation of the energy expenditure along with recommendations specific to each individual will be used. Dietary counseling will be given individually following assessment using a new dietary assessment program called Dietary Assessment Scanning Calculator. Home visit will be done every 3 months by responsible nurses and village health volunteers. Knowledge management will be done through meetings between participants and villages with support from trained nurses. Situation analysis and community action will be encouraged to address four health behaviors.
Primary Outcome Measure Information:
Title
Dementia
Description
Number of participants with dementia. Incident dementia will be diagnosed by medical specialists (Neuro-Med) following a battery of screening tests, including mini-mental state exam, depression and clock drawing tests.
Time Frame
10 years
Secondary Outcome Measure Information:
Title
Type 2 diabetes mellitus
Description
Number of participants with type 2 diabetes mellitus. Diabetes mellitus is biochemically and clinically diagnosed.
Time Frame
3, 5 and 10 years
Title
Cardiovascular disease
Description
Number of participants with cardiovascular disease. Clinical diagnosis of cardiovascular disease. Diagnostic information will be obtained from medical records review and service reimbursement data.
Time Frame
5 and 10 years
Title
Cancers
Description
Number of participants with cancers. Diagnostic information will be obtained from medical records review and service reimbursement data.
Time Frame
5 and 10 years
Title
Chronic obstructive pulmonary disease
Description
Number of participants with physician-diagnosed chronic obstructive pulmonary disease. Diagnostic information will be obtained from medical records review and service reimbursement data.
Time Frame
5 and 10 years
Title
Mortality
Description
All-cause mortality retrieved from death certificate database, which captures deaths nationwide, dates of death and related causes.
Time Frame
5 and 10 years
Title
Blood sugar
Description
Blood sugar assessed as fasting plasma glucose and glycated hemoglobin (HbA1c)
Time Frame
1, 2, 5 and 10 years
Title
Blood lipids
Description
Blood lipids include total, LDL- and HDL-cholesterol and triglyceride
Time Frame
1, 2, 5 and 10 years
Other Pre-specified Outcome Measures:
Title
Physical activity levels
Description
Physical activity levels assessed using the global physical activity questionnaire (GPAQ)
Time Frame
1, 2, 5 and 10 years
Title
Diet
Description
Diet assessed by 24 hour food recall
Time Frame
1, 2, 5 and 10 years
Title
Prevalence of current smokers
Description
Percentage of current smokers in the study samples
Time Frame
1, 2, 5 and 10 years
Title
Prevalence of alcohol consumption
Description
Percentage of those who report alcohol consumption
Time Frame
1, 2, 5 and 10 years
Title
Cognitive function
Description
Cognitive function assessed by MMSE score
Time Frame
2, 5 and 10 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
45 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Thai nationality Age 45-75 years Have resided in the Ubon Ratchathani's villages for at least 1 year Those giving written informed consent to participate in the research project Exclusion Criteria: Known case of dementia, chronic kidney disease, diabetes, chronic obstructive pulmonary disease, cancers and cardiovascular disease Unable to communicate well in Thai Unable to move or get physical exercise Those at risk of having complications from performing physical exercise Those diagnosed with cancers of any system/ organ or those in the end of life period
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Prasert Boongird, MD
Organizational Affiliation
Dementia Association of Dementia
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Parinya Chamnan, MD, PhD
Organizational Affiliation
Sanpasitthiprasong Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Wannee Nitiyanant, MD
Organizational Affiliation
Siriraj Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Wichai Aekplakorn, MD, PhD
Organizational Affiliation
Ramathibodi Hospital, Mahidol University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Chanida Pachotikarn, PhD
Organizational Affiliation
Thai Dietetic Society
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Chaicharn Deerochanawong, MD
Organizational Affiliation
Rajvithi Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Surasak Kantachuvesiri, MD, PhD
Organizational Affiliation
Ramathibodi Hospital, Mahidol University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Wallaya Jongjaroenprasert, MD
Organizational Affiliation
Ramathibodi Hospital, Mahidol University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Atiporn Ingsathit, MD, PhD
Organizational Affiliation
Ramathibodi Hospital, Mahidol University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Win Techakehakij, MD, PhD
Organizational Affiliation
Lampang Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Phanida Krittayapoositpot, MD
Organizational Affiliation
Dementia Association of Thailand
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Worawan Chailimpamontri, MD
Organizational Affiliation
Bhumibol Adulyadej Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Ampika Mangklabruks, MD
Organizational Affiliation
Faculty of Medicine, Chiangmai University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Sanpasitthiprasong Hospital
City
Muaeng
State/Province
Ubon Ratchathani
ZIP/Postal Code
34000
Country
Thailand

12. IPD Sharing Statement

Learn more about this trial

Impact of Lifestyle Modification on the Development of Dementia, Chronic Kidney Disease, Diabetes, Chronic Obstructive Pulmonary Disease, Cancers and Cardiovascular Disease in a Thai General Population

We'll reach out to this number within 24 hrs